Cardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep Apnea
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Obstructive sleep apnea subjects the failing heart to adverse hemodynamic and adrenergic loads and may thereby contribute to the progression of heart failure. We hypothesized that treatment of obstructive sleep apnea by continuous positive airway pressure in patients with heart failure would improve left ventricular systolic function. METHODS: Twenty-four patients with a depressed left ventricular ejection fraction (45 percent or less) and obstructive sleep apnea who were receiving optimal medical treatment for heart failure underwent polysomnography. On the following morning, their blood pressure and heart rate were measured by digital photoplethysmography, and left ventricular dimensions and left ventricular ejection fraction were assessed by echocardiography. The subjects were then randomly assigned to receive medical therapy either alone (12 patients) or with the addition of continuous positive airway pressure (12 patients) for one month. The assessment protocol was then repeated. RESULTS: In the control group of patients who received only medical therapy, there were no significant changes in the severity of obstructive sleep apnea, daytime blood pressure, heart rate, left ventricular end-systolic dimension, or left ventricular ejection fraction during the study. In contrast, continuous positive airway pressure markedly reduced obstructive sleep apnea, reduced the daytime systolic blood pressure from a mean (+/-SE) of 126+/-6 mm Hg to 116+/-5 mm Hg (P=0.02), reduced the heart rate from 68+/-3 to 64+/-3 beats per minute (P=0.007), reduced the left ventricular end-systolic dimension from 54.5+/-1.8 to 51.7+/-1.2 mm (P=0.009), and improved the left ventricular ejection fraction from 25.0+/-2.8 to 33.8+/-2.4 percent (P<0.001). CONCLUSION: In medically treated patients with heart failure, treatment of coexisting obstructive sleep apnea by continuous positive airway pressure reduces systolic blood pressure and improves left ventricular systolic function. Obstructive sleep apnea may thus have an adverse effect in heart failure that can be addressed by targeted therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In small and select groups of patients with OSA and hFrEF, CPAP has been associated with reduced systolic BP743,744 and heart rate,743 small but inconsistent changes in left ventricular EF (LVEF),743–747 decreased overnight urinary norepinephrine excretion,746 improved QOL,743,746 improved mean sleep-related SaO2,745 and decreased pulmonary artery systolic pressure.747”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [743]
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,638
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Committee Members, Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,442
Research works printed but not linked: 1
- Daly PA, 1990, Circulation, 82, I
Cited by
Items 101–200 of 1,000
Factors Associated With the Development of Expertise in Heart Failure Self-Care
Riegel, B., Vaughan Dickson, V., Goldberg, L. R., & Deatrick, J. A. (2007) · Nursing Research · doi:10.1097/01.nnr.0000280615.75447.f7 · Cited by 183
“Sleep disordered breathing is one of many causes of excessive daytime sleepiness (Kaneko et al., 2003), and sleep disordered breathing was diagnosed more commonly in those poor in self-care than others.”
BackgroundIII Diretriz Brasileira de Insuficiência Cardíaca Crônica
Bocchi, E. A., Marcondes‐Braga, F. G., Ayub‐Ferreira, S. M., Rohde, L. E. P., Junior, W. A. D. O., Almeida, D. R., Moreira, M. D. C. V., Bestetti, R. B., Bordignon, S., Azevedo, C., et al. (2009) · Americanae (AECID Library) · doi:10.1590/s0066-782x2009002000001 · Cited by 170
Colish, J., Walker, J. R., Elmayergi, N., Almutairi, S., Alharbi, F., Lytwyn, M., Francis, A., Bohonis, S., Zeglinski, M., Kirkpatrick, I. D. C., et al. (2012) · Chest · doi:10.1378/chest.11-0615 · Cited by 168
Effects of Exercise Training in Patients with Chronic Heart Failure and Sleep Apnea
Ueno, L. M., Drager, L. F., Rodrigues, A. C. T., Rondon, M. U. P. B., Braga, A. M. F. W., Mathias, W., Krieger, E. M., Barretto, A. C. P., Middlekauff, H. R., Lorenzi-Filho, G., et al. (2009) · Sleep · doi:10.1093/sleep/32.5.637 · Cited by 167
Sleep: important considerations for the prevention of cardiovascular disease
Grandner, M. A., Alfonso-Miller, P., Fernandez-Mendoza, J., Shetty, S., Shenoy, S., & Combs, D. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000324 · Cited by 166
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 159
Obstructive sleep apnea and cardiovascular disease
Butt, M., Dwivedi, G., Khair, O., & Lip, G. Y. H. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.021 · Cited by 161
Heart failure and sleep disorders
on behalf of the Italian Society of Cardiology (SIC) Working Group on Heart Failure members, Parati, G., Lombardi, C., Castagna, F., Mattaliano, P., Filardi, P. P., & Agostoni, P. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.71 · Cited by 165
Iftikhar, I. H., Bittencourt, L., Youngstedt, S. D., Ayas, N., Cistulli, P. A., Schwab, R. J., Durkin, M. W., & Magalang, U. J. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.06.001 · Cited by 174
Adaptive Servoventilation for Treatment of Sleep-Disordered Breathing in Heart Failure
Sharma, B. K., Bakker, J. P., McSharry, D. G., Desai, A. S., Javaheri, S., & Malhotra, A. (2012) · Chest · doi:10.1378/chest.12-0815 · Cited by 163
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 159
Obstructive sleep apnoea and stroke
Yaggi, H. K., & Mohsenin, V. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00766-5 · Cited by 176
Cardiopulmonary Interactions: Physiologic Basis and Clinical Applications
Pinsky, M. R. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201704-339fr · Cited by 159
McKelvie, R. S., Moe, G. W. P. L., Cheung, A. W., Costigan, J., Ducharme, A., Estrella-Holder, E., Ezekowitz, J. A., Floras, J. S., Giannetti, N., Grzeslo, A., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.03.011 · Cited by 168
Self-citationThe Link Between Obstructive Sleep Apnea and Cardiovascular Disease
Bauters, F., Rietzschel, E. R., Hertegonne, K. B. C., & Chirinos, J. A. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0556-z · Cited by 153
van Bilsen, M., Patel, H. C., Bauersachs, J., Böhm, M., Borggrefe, M., Brutsaert, D., Coats, A. J. S., de Boer, R. A., de Keulenaer, G. W., Filippatos, G. S., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.921 · Cited by 148
Self-citationCardiovascular Consequences of Sleep Apnea
Selim, B. J., Won, C. H. J., & Yaggi, H. K. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.010 · Cited by 163
“Such treatment also increases vagal modulation of heart rate with consequent increase of HRV(131) and LVEF.(129) It is known that HF patients with moderate to severe OSA have an increased risk of death independently of confounding factors.”
BackgroundObstructive Sleep Apnea Syndrome and Cardiovascular Diseases
Fava, C., Montagnana, M., Favaloro, E., Guidi, G., & Lippi, G. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273092 · Cited by 148
Sleep and Cardiovascular Disease: An Overview
Malhotra, A., & Loscalzo, J. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.004 · Cited by 150
Obstructive Sleep Apnea-Hypopnea Syndrome
Olson, E. J., Moore, W. R., Morgenthaler, T. I., Gay, P. C., & Staats, B. A. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1545 · Cited by 167
Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients
Abe, H., Takahashi, M., Yaegashi, H., Eda, S., Tsunemoto, H., Kamikozawa, M., Koyama, J., Yamazaki, K., & Ikeda, U. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1164-z · Cited by 147
Egea, C. J., Aizpuru, F., Pinto, J. A., Ayuela, J. M., Ballester, E., Zamarrón, C., Sojo, A., Montserrat, J. M., Barbe, F., & Cortés, J. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.06.018 · Cited by 147
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
Samson, R., Jaiswal, A., Ennezat, P. V., Cassidy, M., & Le Jemtel, T. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002477 · Cited by 145
Obstructive Sleep Apnea, Cardiovascular Disease, and Pulmonary Hypertension
Golbin, J. M., Somers, V. K., & Caples, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-143mg · Cited by 147
“Kaneko and colleagues ( 71 ) reported an approximately 9% increase in LV ejection fraction (LVEF) and significant reductions in BP after just 1 month of CPAP therapy.”
BackgroundThe Role of Sleep in Cardiovascular Disease
Jaspan, V. N., Greenberg, G. S., Parihar, S., Park, C. M., Somers, V. K., Shapiro, M. D., Lavie, C. J., Virani, S. S., & Slipczuk, L. N. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01207-5 · Cited by 161
“…45% tested the addition of CPAP to optimal medical therapy, and after one month, showed a significant improvement in mean systolic BP (‑10 mmHg, p = 0.02), reduction in LV end‑systolic diameter (‑2.8 mm, p = 0.009), and recovery of LVEF (+ 8.8%, p 0.001) as assessed by echocardiography [115].”
MethodInfluentialClinical manifestations of sleep apnea.
Stansbury, R. C., & Strollo, P. J. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.09.13 · Cited by 177
“reported that CPAP therapy for OSA improves cardiovascular parameters including blood pressure and left ventricular systolic function in participants with CHF supporting the notion that obstructive apnea may represent a modifiable factor in the care of these types of patients (31).”
BackgroundPalliative Care for Patients With Heart Failure
Pantilat, S. Z. (2004) · JAMA · doi:10.1001/jama.291.20.2476 · Cited by 141
Increased long-term mortality in heart failure due to sleep apnoea is not yet proven
Roebuck, T., Solin, P., Kaye, D. M., Bergin, P., Bailey, M., & Naughton, M. T. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00060404 · Cited by 138
“Indeed, CPAP has been shown to augment cardiac function in CSA [18] and OSA patients [ 19 , 20], but there are scarce data concerning survival.”
BackgroundQureshi, A., Ballard, R. D., & Nelson, H. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.031 · Cited by 171
Influence of the Cardiomyocyte Circadian Clock on Cardiac Physiology and Pathophysiology
Martino, T. A., & Young, M. E. (2015) · Journal of Biological Rhythms · doi:10.1177/0748730415575246 · Cited by 130
“Conversely, maintaining daily physiology, such as with nocturnal treatment with continuous positive airway pressure (CPAP), reverses the disturbance and reduces the cardiovascular consequences (Gilman et al., 2008; Kaneko et al., 2003; Mansfield et al., 2004; Usui et al., 2005).”
BackgroundThe importance of sleep-disordered breathing in cardiovascular disease
Linz, D., Woehrle, H., Bitter, T., Fox, H., Cowie, M., Böhm, M., & Oldenburg, O. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0859-7 · Cited by 150
“Two randomised trials evaluating the effect of CPAP therapy in patients with OSA and HF showed significant improvements in LVEF after 1 and 3 months [88, 89].”
Sleep in Hospitalized Older Adults
Stewart, N. H., & Arora, V. M. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.09.012 · Cited by 145
“Moreover, treatment of OSA with CPAP in patients with post acute stroke or systolic heart failure improves outcomes.(41,56,57) The presence of a highly treatable and very prevalent disorder such as sleepdisordered breathing in such patients warrants a process for better and earlier recognition and treatment.”
BackgroundRisk factors for heart failure
Kenchaiah, S., Narula, J., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.016 · Cited by 157
“In small controlled studies on HF patients with coexisting obstructive sleep apnea, short-term (1- to 3-month) continuous positive airway pressure has been associated with a reduction in systolic BP, heart rate, and sympathetic activity and an improvement in LV systolic function [102,103].”
BackgroundRole of obstructive sleep apnea in cardiovascular disease
Monahan, K., & Redline, S. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834b806a · Cited by 133
Sleep apnea and cardiovascular risk
Floras, J. S. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.08.009 · Cited by 144
Self-citationSleep-disordered breathing and cardiovascular disease
Phillips, B. A. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.09.007 · Cited by 143
Obstructive Sleep Apnea and Cardiovascular Disease
Kato, M., Adachi, T., Koshino, Y., & Somers, V. K. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0364 · Cited by 139
Sleep-Disordered Breathing and Cardiovascular Disorders
Budhiraja, R., Budhiraja, P., & Quan, S. F. (2010) · Respiratory Care · doi:10.4187/respcare.10551322 · Cited by 127
Lévy, P., Ryan, S., Oldenburg, O., & Parati, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00004513 · Cited by 121
Prevalence of sleep apnoea in diabetic patients
Schober, A.-K., Neurath, M. F., & Harsch, I. A. (2011) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2010.00216.x · Cited by 124
“Given the high cardiovascular risk of diabetic patients, other positive effects of nCPAP have to be considered: Several studies proved the positive effect of nCPAP therapy concerning blood pressure (39), heart failure (40), cardiovascular events (15) and atrial fibrillation (41): Pepperell et al.”
BackgroundLyons, O. D., Floras, J. S., Logan, A. G., Beanlands, R., Cantolla, J. D., Fitzpatrick, M., Fleetham, J., John Kimoff, R., Leung, R. S. T., Lorenzi Filho, G., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.790 · Cited by 121
Self-citationCowie, M. R., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M.-P., Erdmann, E., Levy, P., Simonds, A., Somers, V. K., Zannad, F., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft051 · Cited by 123
Obesity and the lung: 3 {middle dot} Obesity, respiration and intensive care
Malhotra, A., & Hillman, D. (2008) · Thorax · doi:10.1136/thx.2007.086835 · Cited by 121
“61 Increases in pulmonary artery pressures (PAP) are debated in OSA.”
Backgroundvon Haehling, S., Arzt, M. E., Doehner, W., Edelmann, F., Evertz, R., Ebner, N., Herrmann‐Lingen, C., Garfias‐Veitl, T., Koziolek, M. J., Noutsias, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1838 · Cited by 126
Bradley, T. D., Logan, A. G., Lorenzi‐Filho, G., Kimoff, R. J., Durán‐Cantolla, J., Arzt, M. E., Redolfi, S., Parati, G., Kasai, T., Dunlap, M. E., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00374-0 · Cited by 132
Self-citationKhattak, H. K., Hayat, F., Pamboukian, S. V., Hahn, H. S., Schwartz, B. P., & Stein, P. K. (2018) · Texas Heart Institute Journal · doi:10.14503/thij-15-5678 · Cited by 118
“Stroke volume and LVEF were reduced in acute CPAP administration, whereas 7 weeks of chronic CPAP resulted in improved stroke volume and an absolute increase of 5% in LVEF.”
InfluentialA clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Maeder, M. T., Schoch, O. D., & Rickli, H. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s74703 · Cited by 126
Smith, L. A., Vennelle, M., Gardner, R. S., McDonagh, T. A., Denvir, M. A., Douglas, N. J., & Newby, D. E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm131 · Cited by 120
“Compliance with CPAP therapy in this study was reasonable, particularly when the reduced total sleep time is considered, but was poorer than that achieved in other studies.(14,15) This was despite careful education, initiation of treatment in-laboratory, and the provision of ongoing support, suggesting that CPAP may n…”
MethodInfluentialChan, C. T., Hanly, P., Gabor, J. Y., Picton, P. E., Pierratos, A., & Floras, J. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00384.x · Cited by 122
“In the non-ESRD population, abolition of obstructive apnea and hypoxemia during sleep by nasal continuous positive airway pressure (CPAP) has been shown to significantly lower daytime systolic blood pressure, heart rate, and augment left ventricular systolic performance [32, 33].”
BackgroundSelf-citationPrevalence of symptoms and risk of sleep apnea in middle-aged Saudi males in primary care
BaHammam, A. S., Alrajeh, M. S., Al-Jahdali, H. H., & BinSaeed, A. A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4265 · Cited by 131
Relationship between sleep apnoea and mortality in patients with ischaemic heart failure
Yumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2009) · Heart · doi:10.1136/hrt.2008.160952 · Cited by 112
Self-citationNakashima, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl219 · Cited by 113
Sleep-Disordered Breathing in Heart Failure
Pearse, S. G., & Cowie, M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.492 · Cited by 119
Pinsky, M. R. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3282efad97 · Cited by 109
Floras, J. S. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.003 · Cited by 122
Self-citationCongestive Heart Failure: Diagnosis, Pathophysiology, Therapy, and Implications for Respiratory Care
Figueroa, M. S., & Peters, J. I. (2006) · Respiratory Care · doi:10.4187/respcare.06510403 · Cited by 144
Treatment of Sleep Apnea in Heart Failure
Arzt, M., & Bradley, T. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1745pp · Cited by 105
Self-citationHellawell, J. L., & Margulies, K. B. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00247.x · Cited by 112
Kasai, T. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.05.013 · Cited by 120
Adaptive servo-ventilation in heart failure patients with sleep apnea: A real world study
Hastings, P. C., Vazir, A., Meadows, G. E., Dayer, M., Poole-Wilson, P. A., McIntyre, H. F., Morrell, M. J., Cowie, M., & Simonds, A. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.022 · Cited by 111
Morbidities associated with obstructive sleep apnea
Vijayan, V. K. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.44 · Cited by 99
Rotenberg, B. W., Vicini, C., Pang, E. B., & Pang, K. P. (2016) · Journal of Otolaryngology - Head & Neck Surgery · doi:10.1186/s40463-016-0136-4 · Cited by 95
“First, although a large number of RCTs have been published documenting the benefits of CPAP relative to sub-therapeutic (sham) CPAP [3–33], an oral placebo [32, 34–43], conservative or no therapy [9, 21, 42, 44–53], various oral appliances [3, 4, 35, 50, 54–62], and postural therapy [63–66], numerous limitations of th…”
BackgroundMethodPolysomnographic Respiratory Abnormalities in Asymptomatic Individuals
Pavlova, M. K., Duffy, J. F., & Shea, S. A. (2008) · Sleep · doi:10.1093/sleep/31.2.241 · Cited by 100
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · EP Europace · doi:10.1093/europace/euv191 · Cited by 111
“107,113,114 Cardiac arrhythmias in patients with chronic kidney disease and heart failure Chronic kidney disease is defined as evidence of renal impairment or a glomerular filtration rate (GFR) of ≤ 60 ml/min/1.73 m 2 .”
InfluentialObstructive sleep apnea screening and postoperative mortality in a large surgical cohort
Lockhart, E. M., Willingham, M. D., Abdallah, A. B., Helsten, D. L., Bedair, B. A., Thomas, J., Duntley, S., & Avidan, M. S. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.018 · Cited by 98
“There are many reported benefits of therapy with CPAP, including positive effects on arterial stiffness [30], reduction of inflammatory mediators associated with OSA [31], reduction in systolic blood pressure and improved left ventricular systolic function [32–34], and reduction of the risk for death and hospitali zat…”
Hall, A. B., Ziadi, M. C., Leech, J. A., Chen, S.-Y., Burwash, I. G., Renaud, J., deKemp, R. A., Haddad, H., Mielniczuk, L. M., Yoshinaga, K., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005893 · Cited by 97
“Patients were instructed to use CPAP at the determined pressure every night for at least 6 hours.(19) Whenever possible, CPAP compliance was assessed with the use of the machines’ hour usage meters, and patients were contacted approximately biweekly to optimize mask tolerance, fit, and compliance during the study peri…”
MethodResultSelf-citationHypertension and obstructive sleep apnoea syndrome: current perspectives
Baguet, J.-P., Barone‐Rochette, G., & Pépin, J. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.147 · Cited by 105
Iseki, K., Tohyama, K., Matsumoto, T., & Nakamura, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.249 · Cited by 104
Chronic Kidney Disease in Japan
Iseki, K. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0906 · Cited by 105
“In the case of sleep apnea, continuous positive airway pressure is effective for preventing CVD and maybe CKD (66, 67).”
BackgroundLyons, O. D., & Bradley, T. D. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.017 · Cited by 107
Self-citationD'Apuzzo, M. R., & Browne, J. A. (2012) · The Journal of Arthroplasty · doi:10.1016/j.arth.2012.03.025 · Cited by 95
“Obstructive sleep apnea (OSA) is a common sleeprelated breathing disorder, affecting 2% to 10% of the general North American population and is associated with an increased risk of cardiovascular morbidity and mortality [1].”
BackgroundFietze, I., Blau, A., Glos, M., Theres, H., Baumann, G., & Penzel, T. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.09.008 · Cited by 98
“This beneficial effect has been shown in patients with chronic heart failure (CHF) and OSA as well [10,11].”
BackgroundMethodResultInfluentialCastro‐Grattoni, A. L., Alvarez-Buvé, R., Torres, M., Farré, R., Montserrat, J. M., Dalmases, M., Almendros, I., Barbé, F., & Sánchez‐de‐la‐Torre, M. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.11.010 · Cited by 102
Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Arzt, M., Schroll, S., Series, F., Lewis, K., Benjamin, A., Escourrou, P., Luigart, R., Kehl, V., & Pfeifer, M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00083312 · Cited by 95
“Most other trials in this field have been single centre [16, 19, 25, 27, 32, 35].”
BackgroundResultConsequences of Circadian and Sleep Disturbances for the Cardiovascular System
Alibhai, F. J., Tsimakouridze, E. V., Reitz, C. J., Pyle, W. G., & Martino, T. A. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.01.015 · Cited by 102
Gilman, M. P., Floras, J. S., Usui, K., Kaneko, Y., Leung, R. S. T., & Bradley, T. D. (2008) · Clinical Science · doi:10.1042/cs20070172 · Cited by 94
“Our findings therefore indicate that, in addition to improving LV systolic function and reducing sympathetic nervous system activity [ 17 ,18,26], CPAP improves parasympathetic modulation of HR in patients with heart failure with OSA during wakefulness within 2 h following nocturnal CPAP use.”
Self-citationYumino, D., Kasai, T., Kimmerly, D., Amirthalingam, V., Floras, J. S., & Bradley, T. D. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0894oc · Cited by 92
Self-citationIshida, K., Kato, M., Kato, Y., Yanagihara, K., Kinugasa, Y., Kotani, K., Igawa, O., Hisatome, I., Shigemasa, C., & Somers, V. K. (2009) · CHEST Journal · doi:10.1378/chest.08-1431 · Cited by 93
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.
(2006) · Europe PMC (PubMed Central) · Cited by 129
Feltner, C., Wallace, I. F., Aymes, S., Cook Middleton, J., Hicks, K. L., Schwimmer, M., Baker, C., Balio, C. P., Moore, D., Voisin, C. E., et al. (2022) · JAMA · doi:10.1001/jama.2022.18357 · Cited by 80
Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure
Quintana-Gallego, E., Villa-Gil, M., Carmona-Bernal, C., Botebol-Benhamou, G., Martínez-Martínez, Á., Sánchez-Armengol, Á., Polo-Padillo, J., & Capote, F. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00140603 · Cited by 90
“This association is particularly relevant due to the high prevalence of both conditions [5, 6] and the adverse prognostic implications of breathing disorders in heart failure [7, 8]. Recent studies [9, 10 ] have provided important insight into the pathophysiology of sleep apnoea syndrome in patients with congestive he…”
BackgroundObstructive sleep apnea/hypopnea and systemic hypertension
Durán‐Cantolla, J., Aizpuru, F., Martínez‐Null, C., & Barbé, F. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.11.001 · Cited by 113
Randerath, W. J., Galetke, W., Stieglitz, S., Laumanns, C., & Schäfer, T. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.02.011 · Cited by 89
Khayat, R. N., Jarjoura, D., Patt, B., Yamokoski, T., & Abraham, W. T. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.05.005 · Cited by 86
“Treatment of (OSA) with Continuous Positive Airway Pressure (CPAP) in ambulatory patients with systolic heart failure improves cardiac function(20,21).”
BackgroundKauta, S. R., Keenan, B. T., Goldberg, L. R., & Schwab, R. J. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4096 · Cited by 84
“Although the impact of SDB on underlying cardiac disease 5,8,9 and the benefits of PAP treatment 22,23,25,30 have been well documented in prior studies, to our knowledge, our study is ‡ Partial users were significant different from full users (p = 0.020).”
InfluentialSériès, F., Kimoff, R. J., Morrison, D., Leblanc, M. H., Smilovitch, M., Howlett, J., Logan, A. G., Floras, J. S., & Bradley, T. D. (2005) · Chest · doi:10.1378/chest.127.5.1507 · Cited by 83
Self-citationObstructive sleep apnoea and cardiovascular disease
Hamilton, G. S., Solin, P., & Naughton, M. T. (2004) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2004.00596.x · Cited by 89
Relationship of Systolic BP to Obstructive Sleep Apnea in Patients With Heart Failure
Sin, D. D., Fitzgerald, F. S., Parker, J. D., Newton, G. E., Logan, A. G., Floras, J. S., & Bradley, T. D. (2003) · CHEST Journal · doi:10.1378/chest.123.5.1536 · Cited by 82
Self-citationEffects of oral appliances and CPAP on the left ventricle and natriuretic peptides
Hoekema, A., Voors, A. A., Wijkstra, P. J., Stegenga, B., van der Hoeven, J. H., Tol, C. G., & de Bont, L. G. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.016 · Cited by 81
“More circumstantial evidence suggests favourable effects of CPAP on myocardial ischemia [12] and congestive heart failure [2].”
BackgroundObstructive sleep apnoea–hypoapnoea syndrome reversibly depresses cardiac response to exercise
Alonso-Fernández, A., García-Río, F., Arias, M. A., Mediano, O., Pino, J. M., Martínez, I., & Villamor, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi621 · Cited by 79
CHEYNE-STOKES RESPIRATION IN PATIENTS WITH CONGESTIVE HEART FAILURE: CAUSES AND CONSEQUENCES
Lorenzi‐Filho, G., Genta, P. R., Figueiredo, A. C., & Inoue, D. P. (2005) · Clinics · doi:10.1590/s1807-59322005000400012 · Cited by 81
“72 Interestingly enough, CHF patients with Cheyne-Stokes respiration 14 and obstructive sleep apnea 75 do not complain of significant subjective sleepiness.”
Sleep in Congestive Heart Failure
Sharma, B. K., Owens, R. L., & Malhotra, A. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.02.009 · Cited by 84
Bronicki, R. A., & ANAS, N. G. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31819887f0 · Cited by 83
Guidelines for sleep studies in adults-a position statement of the Australasian Sleep Association
Douglas, J. A., Chai-Coetzer, C. L., McEvoy, D., Naughton, M. T., Neill, A. M., Rochford, P., Wheatley, J., & Worsnop, C. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.03.019 · Cited by 78
Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea
Vanderveken, O. M., Boudewyns, A. N., Ni, Q., Kashyap, B., Verbraecken, J. A., Backer, W. D., & de Heyning, P. V. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9238-y · Cited by 82
“In 2003, Kaneko and colleagues [56] randomly assigned 24 subjects with LVEF≤45% to either optimal medical treatment or CPAP.”
MethodTaranto‐Montemurro, L., Floras, J. S., Millar, P. J., Kasai, T., Gabriel, J. M., Spaak, J., Coelho, F. M. S., & Bradley, T. D. (2012) · CHEST Journal · doi:10.1378/chest.11-2963 · Cited by 86
Self-citationMalhotra, A., & Owens, R. L. (2010) · Respiratory Care · doi:10.4187/respcare.10551168 · Cited by 99
Slow Waves Promote Sleep-Dependent Plasticity and Functional Recovery after Stroke
Facchin, L., Schöne, C., Mensen, A., Bandarabadi, M., Pilotto, F., Saxena, S., Libourel, P., Bassetti, C. L., & Adamantidis, A. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0373-20.2020 · Cited by 84
“The detrimental effects of sleep disturbances (Kaneko et al., 2003; Baglioni et al., 2016) and the beneficial effect of pharmacological NREM sleep enhancement after stroke support the hypothesis that SWs contribute to brain plasticity underlying poststroke functional and cognitive recovery both in…”
BackgroundLavie, P. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.07.008 · Cited by 94
New developments in the use of positive airway pressure for obstructive sleep apnea.
Donovan, L. M., BOEDER, S. C., Malhotra, A., & Patel, S. R. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.07.30 · Cited by 93
“In short term trials, CPAP has been shown to improve left ventricular ejection fraction in patients with OSA and systolic heart failure (61,62).”
Background
Metadata
- Authors
- Kaneko, Y., Floras, J. S., Usui, K., Plante, J., Tkacova, R., Kubo, T., Ando, S.-I., & Bradley, T. D.
- Affiliations
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-03-27
- Volume
- 348
- Issue
- 13
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022358071
- Cited by
- 1,051
- References
- 40
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 13 · 2023: 24 · 2022: 26 · 2021: 19 · 2020: 22 · 2019: 26 · 2018: 34 · 2017: 43 · 2016: 45 · 2015: 60 · 2014: 48 · 2013: 61 · 2012: 51
- FWCI
- 39.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- continuous positive airway pressure, obstructive sleep apnea, heart failure, left ventricular systolic function, left ventricular ejection fraction, systolic blood pressure, heart rate, left ventricular end-systolic diameter, hemodynamic load
- MeSH terms
- Blood Pressure, Cardiomyopathy, Dilated, Female, Heart Rate, Humans, Male, Middle Aged, Positive-Pressure Respiration, Stroke Volume, Systole, Ventricular Function, Left, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.